Eplerenone [clinicaltrials_resource:f5dfbeea6e8063918503c1a21cbe024b]
The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure [clinicaltrials:NCT00082589]Aldosterone Antagonism in Diastolic Heart Failure [clinicaltrials:NCT00108251]Effects of Eplerenone on Left Ventricular Remodelling Following Heart Attack [clinicaltrials:NCT00132093]Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension [clinicaltrials:NCT00138944]Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT [clinicaltrials:NCT00147563]A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children. [clinicaltrials:NCT00147589]The Long-Term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years [clinicaltrials:NCT00147615]clinicaltrials:NCT00187889Aldosterone and Vascular Disease in Diabetes Mellitus [clinicaltrials:NCT00214825]clinicaltrials:NCT00223717clinicaltrials:NCT00232180Eplerenone, ACE Inhibition and Albuminuria [clinicaltrials:NCT00315016]clinicaltrials:NCT00401856Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives. [clinicaltrials:NCT00407784]clinicaltrials:NCT00430924The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure [clinicaltrials:NCT00505336]Diurnal Variation of Plasminogen Activator Inhibitor-1 [clinicaltrials:NCT00515021]Does Aldosterone Cause Hypertension by a Non-Renal Mechanism? [clinicaltrials:NCT00553722]clinicaltrials:NCT00608465clinicaltrials:NCT00647192clinicaltrials:NCT00649311Eplerenone in Systemic Right Ventricle [clinicaltrials:NCT00703352]clinicaltrials:NCT00749775A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Finding Study to Evaluate the Efficacy and Safety of LCI699, a New Experimental Antihypertensive Drug, in Patients With Essential Hypertension [clinicaltrials:NCT00758524]clinicaltrials:NCT00817635A Study of the Effects of Eplerenone and Amlodipine on Blood Pressure and Basal Metabolic Rate in Obese Hypertensives [clinicaltrials:NCT00825188]Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions [clinicaltrials:NCT00865176]Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions [clinicaltrials:NCT00865618]Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension [clinicaltrials:NCT00980031]Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity [clinicaltrials:NCT00990223]clinicaltrials:NCT01115855Input of the Use of Indometacin in Gitelman Syndrome as Compared to Potassium Sparing Diuretics [clinicaltrials:NCT01146197]clinicaltrials:NCT01176968Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance [clinicaltrials:NCT01237899]clinicaltrials:NCT01275352Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients [clinicaltrials:NCT01302236]Effect of Eplerenone on Endothelial Function in Metabolic Syndrome [clinicaltrials:NCT01319344]LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension [clinicaltrials:NCT01373086]Hypoglycemia and the Mineralocorticoid Receptor [clinicaltrials:NCT01394627]Eplerenone in HIV Associated Abdominal Fat Accumulation [clinicaltrials:NCT01405456]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Eplerenone [clinicaltrials_resource:f5dfbeea6e8063918503c1a21cbe024b]
Bio2RDF identifier
f5dfbeea6e8063918503c1a21cbe024b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f5dfbeea6e8063918503c1a21cbe024b
identifier
clinicaltrials_resource:f5dfbeea6e8063918503c1a21cbe024b
title
Eplerenone
@en
type
label
Eplerenone [clinicaltrials_resource:f5dfbeea6e8063918503c1a21cbe024b]
@en